| Fund ID | 805-1712930922 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 93% |
| Fund | Type | Gross assets |
|---|---|---|
| Ot Pharma Fund III, LLC | Venture Capital | $52M |
| Ot Dapper Fund I, LP | Venture Capital | $39.3M |
| Ot Asia Fintech Fund I, LLC | Venture Capital | $15.7M |
Ot Pharma Fund II, LLC reports $3.9 million in gross assets, among the top 87% of private funds by size.
The stated minimum investment is $100,000.
Ot Pharma Fund II, LLC is managed by Ot Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.